Medicamen Biotech has informed that a meeting of the Board of Directors of the Company will be held on March 31, 2014, inter alia, to consider the Preferential Allotment of Equity Shares & Warrants convertible into Equity Shares to the promoter group.
The above information is a part of company’s filings submitted to BSE.